Literature DB >> 15640607

Misoprostol 50 microg sublingually versus vaginally for labor induction at term: a randomized study.

Eray Caliskan1, Harika Bodur, Semih Ozeren, Aydin Corakci, Sabiha Ozkan, Izzet Yucesoy.   

Abstract

OBJECTIVE: To compare the efficacy of misoprostol 50 mug vaginally and 50 mug sublingually for labor induction at term.
MATERIALS AND METHODS: One hundred and sixty women were randomized to receive misoprostol 50 microg vaginally (n = 80) or 50 microg sublingually misoprostol (n = 80). The doses were given every 4 h (maximum 6 doses). Primary outcome measure was number of cesarean deliveries. Induction to delivery time, delivery within 24 h, the number of misoprostol doses given; the need for oxytocin augmentation, tachysystole and uterine hyperstimulation rates and neonatal outcomes were secondary outcome measures.
RESULTS: The mean induction to delivery time was 748 +/- 379 min in the vaginal group and 711 +/- 425 in the sublingual group (p = 0.56). The number of women delivering within 24 h was 73 (91.3%) in the vaginal group and 74 (92.5%) in the sublingual group (p = 0.78). The mean number of misoprostol doses required was significantly higher in the sublingual group (1.9 +/- 1.2) compared with the vaginal group (1.1 +/- 0.4; p < 0.001). More women in the sublingual group experienced tachysystole (n = 14, 17.5%) compared with the vaginal group (n = 3, 3.8%; p = 0.005). Seven cases (8.8%) in the vaginal group and 12 cases in the sublingual group (15%) required emergent cesarean delivery for fetal heart rate abnormalities (p = 0.22). Other neonatal outcomes including umbilical artery pH, Apgar scores and intensive care unit admission were similar in the two groups.
CONCLUSION: Sublingual misoprostol is as efficacious as vaginal misoprostol for induction of labor. More frequent tachysystole is observed with misoprostol 50 microg sublingually, but neonatal outcomes are similar.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640607     DOI: 10.1159/000083255

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

1.  A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial.

Authors:  David M Haas; Joanne Daggy; Kathleen M Flannery; Meredith L Dorr; Carrie Bonsack; Surya S Bhamidipalli; Rebecca C Pierson; Anthony Lathrop; Rachel Towns; Nicole Ngo; Annette Head; Sarah Morgan; Sara K Quinney
Journal:  Am J Obstet Gynecol       Date:  2019-05-07       Impact factor: 8.661

2.  Sublingual versus Vaginal Misoprostol for the Induction of Labor at Term: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Authors:  Bahia Namavar Jahromi; Foroogh Poorgholam; Gholamhossein Yousefi; Leila Salarian
Journal:  Iran J Med Sci       Date:  2016-03

3.  Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial.

Authors:  Daniele S M B Gattás; Melania M R de Amorim; Francisco E L Feitosa; José R da Silva-Junior; Lívia C G Ribeiro; Gustavo F A Souza; Alex S R Souza
Journal:  Reprod Health       Date:  2020-04-10       Impact factor: 3.223

Review 4.  Buccal or sublingual misoprostol for cervical ripening and induction of labour.

Authors:  G Muzonzini; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

5.  Vaginal versus sublingual misoprostol for labor induction at term and post term: a randomized prospective study.

Authors:  Sedigheh Ayati; Fatemeh Vahidroodsari; Farnoosh Farshidi; Masoud Shahabian; Monavar Afzal Aghaee
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.